| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
and IL-6 by Human Monocytes 1
* Department of Internal Medicine, Division of Rheumatology, and
Department of Clinical Pathology, Catholic University of Korea, Seoul, Korea; and
Division of Molecular and Life Science, Pohang University of Science and Technology, Pohang, Korea
Vascular endothelial growth factor (VEGF) has been suggested to play a critical role in the pathogenesis of rheumatoid arthritis (RA). We previously identified a novel RRKRRR hexapeptide that blocked the interaction between VEGF and its receptor through the screening of peptide libraries. In this study, we investigated whether anti-VEGF peptide RRKRRR (dRK6) could suppress collagen-induced arthritis (CIA) and regulate the activation of mononuclear cells of RA patients. A s.c. injection of dRK6 resulted in a dose-dependent decrease in the severity and incidence of CIA and suppressed synovial infiltration of inflammatory cells in DBA/1 mice. In these mice, the T cell responses to type II collagen (CII) in lymph node cells and circulating IgG Abs to CII were also dose-dependently inhibited by the peptides. In addition, VEGF directly increased the production of TNF-
and IL-6 from human PBMC. Synovial fluid mononuclear cells of RA patients showed a greater response to VEGF stimulation than the PBMC of healthy controls. The major cell types responding to VEGF were monocytes. Moreover, anti-VEGF dRK6 inhibited the VEGF-induced production of TNF- and IL-6 from synovial fluid mononuclear cells of RA patients and decreased serum IL-6 levels in CIA mice. In summary, we observed first that dRK6 suppressed the ongoing paw inflammation in mice and blocked the VEGF-induced production of proinflammatory cytokines. These data suggest that dRK6 may be an effective strategy in the treatment of RA, and could be applied to modulate various chronic VEGF-dependent inflammatory diseases.
This article has been cited by other articles:
|
|
 |
|
  H. Bruhl, M. Mack, M. Niedermeier, D. Lochbaum, J. Scholmerich, and R. H. Straub Functional expression of the chemokine receptor CCR7 on fibroblast-like synoviocytes Rheumatology, December 1, 2008; 47(12): 1771 - 1774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Visvanathan, C Wagner, J C Marini, D Baker, T Gathany, J Han, D van der Heijde, and J Braun Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab Ann Rheum Dis, April 1, 2008; 67(4): 511 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Tse, A. W. H. Chan, K.-H. Yu, A. D. King, K.-T. Wong, G. G. Chen, R. K. Y. Tsang, and A. B. W. Chan Strong Immunohistochemical Expression of Vascular Endothelial Growth Factor Predicts Overall Survival in Head and Neck Squamous Cell Carcinoma Ann. Surg. Oncol., December 1, 2007; 14(12): 3558 - 3565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chalothorn, J. A. Clayton, H. Zhang, D. Pomp, and J. E. Faber Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains Physiol Genomics, July 18, 2007; 30(2): 179 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Q.M. Chow and S. G. Eckhardt In Reply J. Clin. Oncol., July 1, 2007; 25(19): 2859 - 2861. [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Angelo and R. Kurzrock Vascular Endothelial Growth Factor and Its Relationship to Inflammatory Mediators Clin. Cancer Res., May 15, 2007; 13(10): 2825 - 2830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-W. Park, E.-S. Shin, J.-E. Lee, H.-S. Kwon, E. Chun, S.-S. Kim, Y.-S. Chang, Y.-K. Kim, K.-U. Min, Y.-Y. Kim, et al. Multilocus analysis of atopy in Korean children using multifactor-dimensionality reduction Thorax, March 1, 2007; 62(3): 265 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-S. Lee, S.-A. Yoo, C.-S. Cho, P.-G. Suh, W.-U. Kim, and S. H. Ryu Serum Amyloid A Binding to Formyl Peptide Receptor-Like 1 Induces Synovial Hyperplasia and Angiogenesis J. Immunol., October 15, 2006; 177(8): 5585 - 5594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-U. Kim, S. S. Kang, S.-A. Yoo, K.-H. Hong, D.-G. Bae, M.-S. Lee, S. W. Hong, C.-B. Chae, and C.-S. Cho Interaction of Vascular Endothelial Growth Factor 165 with Neuropilin-1 Protects Rheumatoid Synoviocytes from Apoptotic Death by Regulating Bcl-2 Expression and Bax Translocation J. Immunol., October 15, 2006; 177(8): 5727 - 5735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-A. Yoo, B.-H. Park, G.-S. Park, H.-S. Koh, M.-S. Lee, S. H. Ryu, K. Miyazawa, S.-H. Park, C.-S. Cho, and W.-U. Kim Calcineurin Is Expressed and Plays a Critical Role in Inflammatory Arthritis J. Immunol., August 15, 2006; 177(4): 2681 - 2690. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
